Literature DB >> 2060493

An investigation of Cu2Zn2 superoxide dismutase and its Ile-137 mutant at high pH.

L Banci1, I Bertini, P Turano.   

Abstract

The activity profile of the Cu2Zn2HSOD Ile-137 mutant has a pKa of 9.6, i.e. one unit lower than the wild type (WT). This property has allowed us to investigate the inactive high pH form of the enzyme before denaturation occurs. The electronic and EPR spectra do not change with the above pKa. The 1H NMR spectrum of the Cu2Co2-analog reveals slight decreases in the hyperfine shifts of the protons of His-48 at high pH, which are consistent with a water molecule becoming closer to the copper ion, as detected through water 1H T-1(1) NMR measurements. The affinity of azide at high pH is lower than at low pH, though still sizeable. The WT follows the same pattern up to pH congruent to pKa. It appears that the drop in activity is not related to any major change involving the metal coordination sphere, but is related to changes in the electrostatic potential due to the deprotonation process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060493     DOI: 10.1007/bf00185454

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  19 in total

1.  Properties of the cupric sites in bovine superoxide dismutase studied by nuclear-magnetic-relaxation measurements.

Authors:  N Boden; M C Holmes; P F Knowles
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

2.  Further characterization of human erythrocyte superoxide dismutase.

Authors:  R G Briggs; J A Fee
Journal:  Biochim Biophys Acta       Date:  1978-11-20

3.  Studies of the metal sites of copper proteins. Symmetry of copper in bovine superoxide dismutase and its functional significance.

Authors:  G Rotilio; L Morpurgo; C Giovagnoli; L Calabrese; B Mondovì
Journal:  Biochemistry       Date:  1972-05-23       Impact factor: 3.162

4.  Anion binding to bovine erythrocyte superoxide dismutase. Evidence for multiple binding sites with qualitatively different properties.

Authors:  J A Fee; B P Gaber
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

5.  Total reconstitution of copper-zinc superoxide dismutase.

Authors:  K M Beem; W E Rich; K V Rajagopalan
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

6.  Studies of the metal sites of copper proteins. Ligands of copper in hemocuprein.

Authors:  G Rotilio; A F Agrò; L Calabrese; F Bossa; P Guerrieri; B Mondovì
Journal:  Biochemistry       Date:  1971-02-16       Impact factor: 3.162

7.  Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase.

Authors:  J A Tainer; E D Getzoff; K M Beem; J S Richardson; D C Richardson
Journal:  J Mol Biol       Date:  1982-09-15       Impact factor: 5.469

8.  X-ray absorption edge spectroscopy of Co(II)-binding sites of copper- and zinc-containing proteins.

Authors:  A Desideri; F Comin; L Morpurgo; D Cocco; L Calabrese; B Mondovi; W Maret; G Rotilio
Journal:  Biochim Biophys Acta       Date:  1981-10-28

9.  Structure and mechanism of copper, zinc superoxide dismutase.

Authors:  J A Tainer; E D Getzoff; J S Richardson; D C Richardson
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

10.  Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library.

Authors:  R A Hallewell; F R Masiarz; R C Najarian; J P Puma; M R Quiroga; A Randolph; R Sanchez-Pescador; C J Scandella; B Smith; K S Steimer
Journal:  Nucleic Acids Res       Date:  1985-03-25       Impact factor: 16.971

View more
  1 in total

1.  Use of Selected Scavengers for the Determination of NF-TiO2 Reactive Oxygen Species during the Degradation of Microcystin-LR under Visible Light Irradiation.

Authors:  Miguel Pelaez; Polycarpos Falaras; Vlassis Likodimos; Kevin O'Shea; Armah A de la Cruz; Patrick S M Dunlop; J Anthony Byrne; Dionysios D Dionysiou
Journal:  J Mol Catal A Chem       Date:  2016-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.